| 000 | 01784 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513212441.0 | ||
| 264 | 0 | _c20000621 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 024 | 7 |
_a10.4088/jcp.v61n0503 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGómez, J C | |
| 245 | 0 | 0 |
_aThe safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cMay 2000 |
||
| 300 |
_a335-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAmbulatory Care |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aPirenzepine _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPsychiatric Status Rating Scales _xstatistics & numerical data |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSacristán, J A | |
| 700 | 1 | _aHernández, J | |
| 700 | 1 | _aBreier, A | |
| 700 | 1 | _aRuiz Carrasco, P | |
| 700 | 1 | _aAntón Saiz, C | |
| 700 | 1 | _aFontova Carbonell, E | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 61 _gno. 5 _gp. 335-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/jcp.v61n0503 _zAvailable from publisher's website |
| 999 |
_c10798570 _d10798570 |
||